Cargando…
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
British Epilepsy Association. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275169/ https://www.ncbi.nlm.nih.gov/pubmed/32574838 http://dx.doi.org/10.1016/j.seizure.2020.06.008 |
| _version_ | 1783542730222206976 |
|---|---|
| author | Gómez-Enjuto, Sara Hernando-Requejo, Virgilio Lapeña-Motilva, José Ogando-Durán, Gonzalo Fouz-Ruiz, Daniel Domingo-García, Julio Rodríguez-García, Elena Cemillán-Fernández, Carlos Alberto |
| author_facet | Gómez-Enjuto, Sara Hernando-Requejo, Virgilio Lapeña-Motilva, José Ogando-Durán, Gonzalo Fouz-Ruiz, Daniel Domingo-García, Julio Rodríguez-García, Elena Cemillán-Fernández, Carlos Alberto |
| author_sort | Gómez-Enjuto, Sara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7275169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | British Epilepsy Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72751692020-06-08 Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient Gómez-Enjuto, Sara Hernando-Requejo, Virgilio Lapeña-Motilva, José Ogando-Durán, Gonzalo Fouz-Ruiz, Daniel Domingo-García, Julio Rodríguez-García, Elena Cemillán-Fernández, Carlos Alberto Seizure Clinical Letter British Epilepsy Association. Published by Elsevier Ltd. 2020-08 2020-06-06 /pmc/articles/PMC7275169/ /pubmed/32574838 http://dx.doi.org/10.1016/j.seizure.2020.06.008 Text en © 2020 British Epilepsy Association. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Letter Gómez-Enjuto, Sara Hernando-Requejo, Virgilio Lapeña-Motilva, José Ogando-Durán, Gonzalo Fouz-Ruiz, Daniel Domingo-García, Julio Rodríguez-García, Elena Cemillán-Fernández, Carlos Alberto Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title | Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title_full | Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title_fullStr | Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title_full_unstemmed | Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title_short | Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient |
| title_sort | verapamil as treatment for refractory status epilepticus secondary to pres syndrome on a sars-cov-2 infected patient |
| topic | Clinical Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275169/ https://www.ncbi.nlm.nih.gov/pubmed/32574838 http://dx.doi.org/10.1016/j.seizure.2020.06.008 |
| work_keys_str_mv | AT gomezenjutosara verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT hernandorequejovirgilio verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT lapenamotilvajose verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT ogandodurangonzalo verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT fouzruizdaniel verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT domingogarciajulio verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT rodriguezgarciaelena verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient AT cemillanfernandezcarlosalberto verapamilastreatmentforrefractorystatusepilepticussecondarytopressyndromeonasarscov2infectedpatient |